Leukemia stem cell immunophenotyping tool for diagnostic, prognosis, and therapeutics

Area of Science:

• Hematology
• Cancer Biology
• Stem Cell Biology

Background:

• Cancer stem cells (CSCs) are well-established in leukemia, unlike in many solid tumors.
• Leukemic stem cells (LSCs) arise from accumulated genetic/epigenetic alterations, disrupting normal differentiation.
• LSCs exhibit uncontrolled proliferation and prevent mature cell formation, leading to disease progression.

Purpose of the Study:

• To review and connect immunophenotype data of LSCs across major leukemia types.
• To guide technical advancements in LSC identification and characterization.
• To highlight the diagnostic and therapeutic potential of understanding LSC features.

Main Methods:

• Literature review of existing studies on LSC immunophenotypes in leukemia.
• Analysis of genetic and epigenetic alterations contributing to LSC development.
• Correlation of LSC features with diagnostic and treatment strategies.

Main Results:

• LSCs are characterized by a primitive state with high proliferation potential.
• Distinct immunophenotypic profiles exist for LSCs in various leukemia subtypes.
• LSC identification offers potential for improved diagnostic markers and targeted therapies.

Conclusions:

• LSC research is crucial for advancing stem cell biology and understanding leukemia.
• Characterizing LSC immunophenotypes can refine diagnostic tools and treatment approaches.
• Further investigation into LSC features will enhance leukemia management.